151 related articles for article (PubMed ID: 21621152)
1. Modulation of serum antinuclear antibody levels by levamisole treatment in patients with oral lichen planus.
Lin HP; Wang YP; Chia JS; Sun A
J Formos Med Assoc; 2011 May; 110(5):316-21. PubMed ID: 21621152
[TBL] [Abstract][Full Text] [Related]
2. Modulation of serum smooth muscle antibody levels by levamisole treatment in patients with oral lichen planus.
Wu KM; Wang YP; Lin HP; Chen HM; Chia JS; Sun A
J Formos Med Assoc; 2013 Jun; 112(6):352-7. PubMed ID: 23602020
[TBL] [Abstract][Full Text] [Related]
3. Modulation of serum anti-thyroglobulin and anti-thyroid microsomal autoantibody levels by levamisole in patients with oral lichen planus.
Lin HP; Wang YP; Chia JS; Sun A
J Formos Med Assoc; 2011 Mar; 110(3):169-74. PubMed ID: 21497280
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus.
Sun A; Chia JS; Chang YF; Chiang CP
J Oral Pathol Med; 2002 Apr; 31(4):196-203. PubMed ID: 12076322
[TBL] [Abstract][Full Text] [Related]
5. Levamisole can reduce the high serum tumour necrosis factor-alpha level to a normal level in patients with erosive oral lichen planus.
Sun A; Chia JS; Wang JT; Chiang CP
Clin Exp Dermatol; 2007 May; 32(3):308-10. PubMed ID: 17397355
[TBL] [Abstract][Full Text] [Related]
6. Significantly higher frequencies of presence of serum autoantibodies in Chinese patients with oral lichen planus.
Chang JY; Chiang CP; Hsiao CK; Sun A
J Oral Pathol Med; 2009 Jan; 38(1):48-54. PubMed ID: 18764857
[TBL] [Abstract][Full Text] [Related]
7. Oral lichenoid lesions and serum antinuclear antibodies in Thai patients.
Prucktrakul C; Youngnak-Piboonratanakit P; Kanjanabuch P; Prueksrisakul T; Thongprasom K
J Oral Pathol Med; 2015 Jul; 44(6):468-74. PubMed ID: 25213373
[TBL] [Abstract][Full Text] [Related]
8. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus.
Sun A; Wang JT; Chia JS; Chiang CP
Br J Dermatol; 2005 Jun; 152(6):1187-92. PubMed ID: 15948980
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation by levamisole in patients with recurrent aphthous ulcers or oral lichen planus.
Sun A; Chiang CP; Chiou PS; Wang JT; Liu BY; Wu YC
J Oral Pathol Med; 1994 Apr; 23(4):172-7. PubMed ID: 7913970
[TBL] [Abstract][Full Text] [Related]
10. Levamisole and/or Chinese medicinal herbs can modulate the serum level of squamous cell carcinoma associated antigen in patients with erosive oral lichen planus.
Sun A; Chiang CP
J Oral Pathol Med; 2001 Oct; 30(9):542-8. PubMed ID: 11555157
[TBL] [Abstract][Full Text] [Related]
11. Association of HLA-te22 antigen with anti-nuclear antibodies in Chinese patients with erosive oral lichen planus.
Sun A; Wu YC; Wang JT; Liu BY; Chiang CP
Proc Natl Sci Counc Repub China B; 2000 Apr; 24(2):63-9. PubMed ID: 10809082
[TBL] [Abstract][Full Text] [Related]
12. Prompt healing of erosive oral lichen planus lesion after combined corticosteroid treatment with locally injected triamcinolone acetonide plus oral prednisolone.
Kuo RC; Lin HP; Sun A; Wang YP
J Formos Med Assoc; 2013 Apr; 112(4):216-20. PubMed ID: 23537868
[TBL] [Abstract][Full Text] [Related]
13. Modulation of serum gastric parietal cell antibody level by levamisole and vitamin B12 in oral lichen planus.
Lin HP; Wang YP; Chia JS; Chiang CP; Sun A
Oral Dis; 2011 Jan; 17(1):95-101. PubMed ID: 20659263
[TBL] [Abstract][Full Text] [Related]
14. Treatment effectiveness of levamisole plus prednisolone on oral lichen planus patients with emphasis on levamisole-induced agranulocytosis or pancytopenia.
Lu SY; Chang TF; Lin CJ
J Formos Med Assoc; 2019 Aug; 118(8):1193-1201. PubMed ID: 30922614
[TBL] [Abstract][Full Text] [Related]
15. Anemia and hematinic deficiencies in gastric parietal cell antibody-positive and antibody-negative erosive oral lichen planus patients with thyroid antibody positivity.
Chang JY; Chen IC; Wang YP; Wu YH; Chen HM; Sun A
J Formos Med Assoc; 2016 Nov; 115(11):1004-1011. PubMed ID: 27802920
[TBL] [Abstract][Full Text] [Related]
16. Clinical observation on the treatment of oral lichen planus with total glucosides of paeony capsule combined with corticosteroids.
Zhou L; Cao T; Wang Y; Yao H; Du G; Tian Z; Tang G
Int Immunopharmacol; 2016 Jul; 36():106-110. PubMed ID: 27129091
[TBL] [Abstract][Full Text] [Related]
17. Hematinic deficiencies and anemia statuses in anti-gastric parietal cell antibody-positive or all autoantibodies-negative erosive oral lichen planus patients.
Chang JY; Wang YP; Wu YH; Su YX; Tu YK; Sun A
J Formos Med Assoc; 2018 Mar; 117(3):227-234. PubMed ID: 29292055
[TBL] [Abstract][Full Text] [Related]
18. FoxP3
Sun A; Wu YH; Chang JY; Wang YP; Chiang CP; Chia JS
J Dent Sci; 2021 Mar; 16(2):751-756. PubMed ID: 33854729
[TBL] [Abstract][Full Text] [Related]
19. Association between the clinical severity of oral lichen planus and anti-TPO level in thyroid patients.
Alikhani M; Ghalaiani P; Askariyan E; Khunsaraki ZA; Tavangar A; Naderi A
Braz Oral Res; 2017 Jan; 31():e10. PubMed ID: 28076499
[TBL] [Abstract][Full Text] [Related]
20. Dramatic response to levamisole and low-dose prednisolone in 23 patients with oral lichen planus: a 6-year prospective follow-up study.
Lu SY; Chen WJ; Eng HL
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Dec; 80(6):705-9. PubMed ID: 8680979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
